Sign in

CIK 0001133869

  • Non-accelerated filer
  • Smaller reporting company

CAPRICOR THERAPEUTICS, INC.

Sign in to watch
Ticker
CAPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 310-358-3200
Business address
10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
Former names
Nile Therapeutics, Inc., SMI PRODUCTS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy 10% owner bought 416,666 shares at $2.40 ($999,998)
  11. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 2,100 shares at $2.40 ($5,040)
  12. 4 Open-market buy EVP, General Counsel bought 4,060 shares at $2.40 ($9,744)
  13. 4 Open-market buy Chief Executive Officer bought 10,152 shares at $2.40 ($24,365)
  14. 4 Open-market buy Vice President of Finance bought 2,030 shares at $2.40 ($4,872)
  15. 4 Open-market buy Director bought 100,000 shares at $2.40 ($240,000)
  16. 4 Open-market buy Director bought 91,369 shares at $2.40 ($219,286)
  17. 4 Open-market buy 10% owner bought 833,332 shares at $2.40 ($1,999,997)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 5 Insider Annual Insider Trading Report

Page 10 of 18 · 345 filings